Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prognostic indicators in centroblastic-centrocytic lymphoma.

N R Griffin1, M R Howard, P Quirke

  • 1Department of Pathology, University of Leeds.

Journal of Clinical Pathology
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The observation of starch digestion in blue mussel Mytilus galloprovincialis exposed to microplastic particles under varied food conditions.

PloS one·2021
Same author

Transient receptor potential channels TRPC1/TRPC6 regulate lamina cribrosa cell extracellular matrix gene transcription and proliferation.

Experimental eye research·2020
Same author

The Haemostatic Mechanism and Menstruation: The Role of Intra-Uterine Contraceptive Devices.

Thrombosis and haemostasis·2019
Same author

Yorkshire Case Control Study of Leukaemias and Lymphomas Parallel Multivariate Analyses of Seven Disease Categories.

Leukemia & lymphoma·2016
Same author

Thyroid cytology: a review of current international reporting systems and emerging developments.

Cytopathology : official journal of the British Society for Clinical Cytology·2016
Same author

Modulating non-native aggregation and electrostatic protein-protein interactions with computationally designed single-point mutations.

Protein engineering, design & selection : PEDS·2016
Same journal

Measurement of microinvasive breast carcinoma in the 6th edition WHO Classification: risk of overstaging and clinical implications.

Journal of clinical pathology·2026
Same journal

Development and internal validation of a multifactorial risk model for predicting disease-free survival in oral squamous cell carcinoma.

Journal of clinical pathology·2026
Same journal

HER2-low as a unique subgroup in breast cancer: insights from neoadjuvant chemotherapy response and survival analysis.

Journal of clinical pathology·2026
Same journal

Polyp-forming Dieulafoy lesion of the rectum.

Journal of clinical pathology·2026
Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026
Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026
See all related articles

Flow cytometry assessments of proliferative activity and DNA aneuploidy are significant predictors of survival in centroblastic-centrocytic lymphoma. High proliferative index or DNA aneuploidy indicates poorer survival outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Centroblastic-centrocytic non-Hodgkin's lymphoma (NHL) is a heterogeneous lymphoid malignancy.
  • Accurate prognostic markers are crucial for guiding treatment decisions in NHL.
  • Traditional prognostic factors may not fully capture the biological variability of the disease.

Purpose of the Study:

  • To evaluate the prognostic significance of flow cytometry-assessed ploidy and proliferative index (%S + G2).
  • To assess the role of mitotic counts and histological growth patterns in predicting survival.
  • To determine the predictive value of these parameters in centroblastic-centrocytic lymphoma.

Main Methods:

  • Analysis of biopsy specimens from 60 cases of centroblastic-centrocytic non-Hodgkin's lymphoma before treatment.

Related Experiment Videos

  • Flow cytometry was used to assess ploidy and proliferative index (%S + G2).
  • Mitotic counts, centroblast counts, and histological growth patterns were also evaluated.

    • Main Results:

    • A high proliferative index (≥18%) and DNA aneuploidy were associated with significantly poorer survival.
    • A high mitotic count also correlated with a poor prognosis.
    • Flow cytometric assessments and mitotic counts were identified as significant predictors of survival via multiple regression analysis.

    Conclusions:

    • Proliferative activity assessments using flow cytometry hold significant prognostic potential in centroblastic-centrocytic lymphoma.
    • These assessments can aid in a more accurate characterization of individual tumors.
    • Incorporating flow cytometry data may improve risk stratification and personalized treatment strategies.